期刊
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
卷 66, 期 6, 页码 469-480出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.jnen.0000240472.43038.27
关键词
Alzheimer disease; arnyloid beta; gliosis; neuroinflammation; nonsteroidal anti-inflammatory drugs (NSAIDs); prostanoid; Tg2576 mouse
Prostaglandin (PG) D-2 is produced in activated microglia by the action of hernatopoictic PGD synthase (HPGDS) and plays important roles in neuroinflammation. Because the fact that neuroinflammation accelerates progression of Alzheimer disease (AD) has been documented, we investigated whether PGD(2) is also involved in the pathology of AD. Here, we report that the level of the mRNA of the receptor for PGD(2) (DP1) was increased in AD brains compared with the level in non-AD brains. Immunocytochemical analysis showed HPGDS expression to be localized in the microglia surrounding senile plaques. In situ hybridization studies revealed that DP1 mRNA was specifically localized in microglia and reactive astrocytes within senile plaques of AD brains. In the brain of Tg2576 mice, a model of AD, HPGDS and D(P)1 proteins were mainly localized immunocytochemically in microglia and astrocytes in the plaques, and the levels of their mRNAs increased in parallel with amyloid beta deposition. These results indicate that PGD(2) may act as a mediator of plaque-associated inflammation in AD brain and may explain the pharmacologic mechanisms underlying the favorable response of patients with AD to nonsteroidal anti -inflammatory drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据